IL22 and non-small cell lung carcinoma: Our findings showed that NSCLC cells with IL-22 exposure may acquire EGFR-TKI resistance, and have a better opportunity to survive compared with cells with lower IL-22 levels, suggesting that IL-22 paracrine signaling is indispensable.